Neonatal Jaundice on NICU JCG0013 v2
Bilirubin encephalopathy and kernicterus are now rare but they do still occur3. The purpose of this guideline is to identify those babies at risk of encephalopathy enabling intervention in time to prevent its occurrence.
Elevated bilirubin levels particularly within the first 24 hours or outside the immediate neonatal period can also sometimes signify serious underlying disease and it is these babies also that we would wish to identify
Clinical GuidelinesThis guideline has been approved by the Trust's Clinical Guidelines Assessment Panel as an aid to the diagnosis and management of relevant patients and clinical circumstances. Not every patient or situation fits neatly into a standard guideline scenario and the guideline must be interpreted and applied in practice in the light of prevailing clinical circumstances, the diagnostic and treatment options available and the professional judgement, knowledge and expertise of relevant clinicians. It is advised that the rationale for any departure from relevant guidance should be documented in the patient's case notes.
The Trust's guidelines are made publicly available as part of the collective endeavour to continuously improve the quality of healthcare through sharing medical experience and knowledge. The Trust accepts no responsibility for any misunderstanding or misapplication of this document.